X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2017 - 2023)

X4 Pharmaceuticals (XFOR) reported Long-Term Debt Issuances of $22.5 million for Q3 2023, up 200.0% quarter-over-quarter from $7.5 million in Q4 2020.

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2017 - 2023) Analysis & Trends

X4 Pharmaceuticals has reported Long-Term Debt Issuances for 5 years, with the latest figure at $22.5 million in Q3 2023.

  • For the quarter ending Q3 2023, Long-Term Debt Issuances changed N/A year-over-year to $22.5 million; the trailing twelve-month figure through Dec 2024 stood at $22.5 million (changed 0.0% YoY), and the FY2024 full-year result was $20.0 million, down 11.11% from the prior year.
  • Long-Term Debt Issuances for Q3 2023 stood at $22.5 million, up from $7.5 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $22.5 million in Q3 2023, with the low at $4.9 million in Q1 2020.
  • Historically, Long-Term Debt Issuances has averaged $11.2 million across 3 years, with a median of $8.7 million in 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 2.73 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 X4 Pharmaceuticals 156.06 Mn 156.06 Mn 2.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 22.50 Mn
Sep 30, 2023 22.50 Mn
Dec 31, 2020 7.50 Mn
Dec 31, 2020 7.50 Mn
Mar 31, 2020 4.89 Mn
Mar 31, 2020 4.89 Mn
Jun 30, 2019 9.85 Mn
Jun 30, 2019 9.85 Mn
Dec 31, 2018 9.91 Mn
Dec 31, 2018 9.91 Mn
Dec 31, 2017 5.32 Mn
Dec 31, 2017 5.32 Mn
Sep 30, 2017 19,000.00
Sep 30, 2017 19,000.00
Jun 30, 2017 -4.27 Mn
Jun 30, 2017 -4.27 Mn
Mar 31, 2017 4.94 Mn
Mar 31, 2017 4.94 Mn